Home / Research / Product codes / NQX Medical-device intelligence
NQX: System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen FDA product code NQX: System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code NQX
FDA device name System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Device class 2
Regulation number 866.1640
Medical specialty Microbiology
Review panel MI FDA definition A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of MRSA colonization status for the prevention and control of MRSA infections in healthcare settings. Explore microbiology records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 24 clearance records and 20 recall records in the covered releases, across 14 source company names and 1 product codes. Dated history runs from Mar 18, 2004 to Aug 6, 2025.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 44 matching records Device / record Company in FDA record Source Source date BD MAX DNA Extraction Kit DNA-3 (Swabs in Transport Medium/UTM), Catalog Number 437503. Kit contains 24/2D barcode sample preparation reagent tu… Z-3218-2011 · NQXBecton Dickinson & Co. Recall Sep 16, 2011FDA classification date BD MAX RNA Extraction Kit RNA-3, Catalog Number 437506. Kit contains 24/2D barcode sample preparation reagent tubes. The BD MAX RNA Extraction K… Z-3219-2011 · NQXBecton Dickinson & Co. Recall Sep 16, 2011FDA classification date BD MAX GBS Catalog Number 441772 For In Vitro Diagnostic Use, For use with the BD MAX system.The Sample Preparation Reagent kit consists of 24 (2… Z-3220-2011 · NQXBecton Dickinson & Co. Recall Sep 16, 2011FDA classification date NUCLISENS EASYQ MRSA; NUCLISENS EASYQ ANALYZER; NUCLISENS EASYQ INCUBATOR (110 VOLT); NUCLISENS DIRECTOR V.2.6 K102740 · NQXbioMerieux, Inc. 510(k) May 20, 2011FDA decision date XPERT MRSA/SA BC (BLOOD CULTURE) ASSAY MODEL GXMRSA/SA-BC-10 K101879 · NQXCepheid 510(k) Jul 28, 2010FDA decision date LIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 INSTRUMENT, MODEL 05205727 K091409 · NQXRoche Molecular Systems, Inc. 510(k) Jul 6, 2010FDA decision date Cepheid Xpert MRSA/SA Blood Culture Test for use with the GeneXpert Dx System, manufactured by Cepheid, Sunnyvale, CA.
Medical device, qualitat… Z-1898-2010 · NQXCepheid Recall Jul 1, 2010FDA classification date XPERT MRSA/SA NASAL ASSAY K100822 · NQXCepheid 510(k) Jun 1, 2010FDA decision date BD GENEOHM MRSA ACP ASSAY K093346 · NQXBd Diagnostics (Geneohm Sciences, Inc.) 510(k) Dec 15, 2009FDA decision date BD Diagnostics, BD GeneOhm MRSA Assay, REF: 441242 (200 Reaction Kit) and 441244 (48 Reaction Kit).
For the rapid detection of methicillin resis… Z-1963-2009 · NQXBD Diagnostics (GeneOhm Sciences, Inc) Recall Sep 10, 2009FDA classification date BD GeneOhm MRSA 200 ct, Catalog #441242. IDI-MRSA assay is a qualitative in vitro diagnostic test for the direct detection of nasal colonizatio… Z-0225-2009 · NQXBD Diagnostics (GeneOhm Sciences, Inc) Recall Oct 31, 2008FDA classification date BD GeneOhm MRSA 48 ct, Catalog #441244. IDI-MRSA assay is a qualitative in vitro diagnostic test for the direct detection of nasal colonization … Z-0226-2009 · NQXBD Diagnostics (GeneOhm Sciences, Inc) Recall Oct 31, 2008FDA classification date XPERT MRSA/SA BLOOD CULTURE ASSAY K082140 · NQXCepheid 510(k) Sep 29, 2008FDA decision date XPERT MRSA/SA SSTI ASSAY K080837 · NQXCepheid 510(k) Sep 24, 2008FDA decision date BD GENEOHM STAPHSR ASSAY K071026 · NQXBd Diagnostics (Geneohm Sciences Canada, Inc) 510(k) Dec 20, 2007FDA decision date XPERT MRSA K070462 · NQXCepheid 510(k) Apr 17, 2007FDA decision date Doc-U-Dose Prescription Management System, Item 8-PKIT. The product is packaged and distributed in cartons. Each carton contains 1,000 sets of … Z-0189-2007 · NQXEatonform Inc Recall Nov 16, 2006FDA classification date IDI-MRSA ASSAY K042357 · NQXInfectio Diagnostic (I.D.I.), Inc. 510(k) Oct 22, 2004FDA decision date IDI-MRSA K033415 · NQXInfectio Diagnostic (I.D.I.), Inc. 510(k) Mar 18, 2004FDA decision date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗